# South Korea Closed System Drug Transfer Device Market > South Korea Closed System Drug Transfer Device Market Research Report By Type (Membrane-to-membrane, Needleless System), By Component (Vial Access Devices, Syringe Safety Devices, Accessories, Bag/Line Access Devices), By Closing Mechanism (Push to Turn System, Color-to-color Alignment System, Leur Lock Systems, Click to Lock Systems), By Technology (Compartmentalize Devices, Diaphragm-Based Devices, Air Filtration Devices), and By End-users (Hospitals & Clinics, Specialty Centers, Others) - Growth & Industry Forecast 2025 To 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 10.22% - **2024:** $ 24 Million - **2025:** $ 26.45 Million - **2035:** $ 70 Million - **Key Players:** Baxter International (US), B. Braun Melsungen AG (DE), Cardinal Health (US), Cypress Medical Products (US), ICU Medical (US), Merit Medical Systems (US), Pall Corporation (US), Terumo Corporation (JP) **Report ID:** MRFR/Pharma/47913-HCR · **Pages:** 200 · **Author:** Rahul Gotadki & Garvit Vyas · **Last Updated:** August 24, 2026 **URL:** https://www.marketresearchfuture.com/reports/south-korea-closed-system-drug-transfer-device-market-49667 --- ## Market Summary ## **South Korea Closed System Drug Transfer Device Market Overview** As per MRFR analysis, the South Korea Closed System Drug Transfer Device Market Size was estimated at 21.4 (USD Million) in 2023.The South Korea Closed System Drug Transfer Device Market is expected to grow from 35(USD Million) in 2024 to 644 (USD Million) by 2035. The South Korea Closed System Drug Transfer Device Market CAGR (growth rate) is expected to be around 30.312% during the forecast period (2025 - 2035). ### **Key South Korea Closed System Drug Transfer Device Market Trends Highlighted** The market for closed system drug transfer devices in South Korea is undergoing substantial change as a result of new regulations, improved technology, and a greater emphasis on patient safety. Stricter rules enforced by the Korean government to improve drug safety and reduce the risk of dangerous drug exposure to healthcare personnel are one of the main factors propelling the market. The adoption of closed-system transfer devices in healthcare facilities is fueled by the Ministry of Food and Drug Safety in South Korea, which highlights the necessity for better safety measures in drug handling. As hospitals and pharmacies work to upgrade their systems to meet these rules and enhance patient safety and operational efficiency, market opportunities are opening up. Another area where closed system transfer devices can be useful is in the push for automation in pharmacies, which enables improved workflow management and lowers human error. Devices that provide easy connection with current systems and user-friendly operations are becoming more and more popular, according to recent trends. Additionally, more training and educational initiatives centered on safe medication handling procedures are being offered in South Korean medical facilities as a result of healthcare personnel' growing understanding of the advantages of adopting closed system devices. Manufacturers are further inspired to innovate by this awareness in order to produce sophisticated yet user-friendly technologies that cater to the unique requirements of the South Korean market. Furthermore, sustainability is increasingly being taken into account, impacting product design to maximize effectiveness while minimizing environmental damage. These patterns show a deliberate move toward safer, more effective drug transfer procedures as South Korea's healthcare system develops. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ## **South Korea Closed System Drug Transfer Device Market Drivers** ### **Increase in Oncology Drug Administration** The rise in oncology therapies is a significant driver for the South Korea [Closed System Drug Transfer Device Market](../../../reports/closed-system-drug-transfer-device-market-7733). With the country witnessing a heightened incidence of cancer, the South Korean Ministry of Health and Welfare reported an increase in cancer cases totaling over 30% in the last decade. This sharp rise necessitates safer and more efficient drug administration systems, demonstrating the demand for closed-system drug transfer devices that minimize risks during the handling of hazardous drugs. Established organizations such as the Korean Cancer Association actively engage in supporting oncology research and advocacy, leading to increasing adoption and implementation of safety measures such as closed system devices in hospitals and clinics throughout the region. ### **Regulatory Support and Standards Implementation** Strong regulatory frameworks in South Korea promote the adoption of closed system drug transfer devices, significantly contributing to the growth of the South Korea Closed System Drug Transfer Device Market. The Ministry of Food and Drug Safety (MFDS) has introduced stringent safety regulations focused on the handling of hazardous drugs. Recently, the MFDS enforced guidelines that specifically highlight the use of these devices in hospitals and pharmacies, which is expected to accelerate market expansion as compliance becomes imperative. Such measures ensure that pharmaceutical and healthcare facilities incorporate advanced technology to minimize occupational exposure risks. ### **Technological Advancements in Drug Delivery Systems** Technological innovations play a pivotal role in advancing the South Korea Closed System Drug Transfer Device Market. The rise of automated systems, coupled with sophisticated delivery mechanisms, enhances the safety and efficacy of drug administration processes. South Korean companies, such as Samsung Biologics, are at the forefront of research in this domain, investing in Research and Development (R&D) to create cutting-edge drug delivery technologies. It is reported that over 40% of pharmaceutical companies in South Korea are currently incorporating automated solutions to improve drug handling safety. This trend highlights a growing inclination toward adopting advanced closed-system drug transfer technologies in the healthcare sector. ### **Rising Awareness of Healthcare Worker Safety** Growing awareness regarding the safety of healthcare workers significantly drives the South Korea Closed System Drug Transfer Device Market. Continual exposure to hazardous drugs poses severe health risks for medical staff; thus, increasing attention is being paid to protective measures. Various health organizations in South Korea are conducting awareness campaigns about the importance of safety devices in drug administration. Studies indicate that the implementation of closed system devices can reduce the risk of contamination by over 75%, prompting healthcare facilities to invest in such solutions. This proactive approach towards safeguarding medical professionals reinforces the market's expansion potential. ## **South Korea Closed System Drug Transfer Device Market Segment Insights** ### **Closed System Drug Transfer Device Market Type Insights** The South Korea Closed System Drug Transfer Device Market is witnessing significant growth driven by the increasing prevalence of hazardous drugs and the need for safety in healthcare settings. Among the various types within this market, the Membrane-to-membrane and Needleless System segments play vital roles. The Membrane-to-membrane transfer method is designed to reduce risks associated with drug transfer processes, effectively minimizing exposure to hazardous substances. This technology offers enhanced safety for healthcare professionals administering chemotherapy and other potent medications, aligning with South Korea's rigorous safety standards in health services. Additionally, the Needleless System caters to the growing demand for more user-friendly and safe drug transfer methods, especially in outpatient and home care settings. This system significantly reduces the risk of needlestick injuries, which is crucial given the high standards of hygiene and infection control in South Korean healthcare facilities. The innovative design of these systems is also promoting their adoption in hospitals and clinics across South Korea, bolstering their importance as part of the overall safety protocols employed by medical institutions. Both segments reflect the ongoing shift towards advanced technological solutions in the South Korean pharmaceutical market, driven by innovation, regulatory compliance, and a patient-centered approach in healthcare. The growing emphasis on patient safety and staff protection from hazardous drugs underlines the relevance of these types of devices in today's medical landscape. As South Korea continues to advance its healthcare infrastructure and technology, these segments will likely see further enhancements, ensuring that healthcare professionals are equipped with the safest tools for drug transfer processes. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review ### **Closed System Drug Transfer Device Market Component Insights** The Component segment of the South Korea Closed System Drug Transfer Device Market plays a pivotal role in ensuring the safe and effective transfer of hazardous drugs, driven by rigorous healthcare regulations and the rising prevalence of chronic diseases. Vial Access Devices are particularly significant as they allow healthcare professionals to draw medications with minimal risk of exposure, thus enhancing safety in healthcare settings. Syringe Safety Devices are gaining traction, addressing the critical need for safety in needle handling to prevent needlestick injuries. Accessories support the functionality of various devices, contributing to overall efficiency in drug transfer processes. Bag/Line Access Devices reflect the innovation trend in ensuring secure connections during drug administration, thereby significantly reducing the likelihood of contamination. As South Korea continues to advance its healthcare infrastructure and enhance patient safety protocols, the importance of these components in the Closed System Drug Transfer Device Market is set to grow, aligning with increasing awareness of the need for effective infection control measures and the demand for improved healthcare outcomes. The South Korea Closed System Drug Transfer Device Market statistics indicate that technological advancements and regulatory requirements will further drive innovations in this segment. ### **Closed System Drug Transfer Device Market Closing Mechanism Insights** The Closing Mechanism segment of the South Korea Closed System Drug Transfer Device Market plays a crucial role in ensuring the safe and efficient transfer of hazardous drugs. Among various mechanisms, the Push to Turn System is recognized for its user-friendly design that enhances operational efficiency and safety in healthcare settings, which is especially important given South Korea's commitment to advancing healthcare standards. The Color-to-color Alignment System is notable for its intuitive interface, allowing healthcare professionals to quickly verify secure connections, thereby minimizing the risk of contamination. Leur Lock Systems are widely utilized for their versatility and compatibility with various syringes, making them significant in hospitals and pharmaceutical settings. On the other hand, Click to Lock Systems dominate due to their reliable closing actions, effectively preventing leaks and maintaining sterility during drug transfer. The overall demand for these diverse mechanisms reflects an increasing awareness of safety protocol compliance and the need for innovative solutions to handle hazardous drugs safely and efficiently. As the market evolves, ongoing Research and Development will likely enhance these systems further, addressing the ever-growing healthcare challenges within the South Korean context. ### **Closed System Drug Transfer Device Market Technology Insights** The South Korea Closed System Drug Transfer Device Market, classified under various technologies, has shown significant growth potential driven by the increasing demand for safe drug handling in healthcare settings. Compartmentalized devices are essential in preventing contamination during the transfer of hazardous drugs, making them a preferred choice in hospitals and pharmacies. Diaphragm-based devices serve an important role by minimizing the risk of leakage, thus ensuring the safety of healthcare workers and patients alike, while air filtration devices are crucial for maintaining a contamination-free environment in drug preparation areas. The growing focus on safety regulations and compliance in the pharmaceutical industry further fuels the adoption of these technologies. With advancements in technology and innovation, the segmentation within this market is becoming increasingly significant, enhancing the overall efficiency and safety of drug transfer practices in South Korea's healthcare sector. The continuous push towards safer medication practices is expected to drive further developments across these various technological solutions, making them integral to the evolving landscape of the South Korea Closed System Drug Transfer Device Market. ### **Closed System Drug Transfer Device Market End-user Insights** The South Korea Closed System Drug Transfer Device Market showcases a diverse range of End-users, prominently featuring Hospitals and Clinics, Specialty Centers, and others each playing a vital role in enhancing patient safety and minimizing risks associated with hazardous drugs. Hospitals and Clinics are crucial as they implement advanced drug transfer solutions to improve efficiency in medication administration, thereby ensuring compliance with stricter health regulations and enhancing patient outcomes. Specialty Centers have also gained importance due to their focus on specific medical conditions, requiring tailored drug transfer systems that cater to unique needs. Amid increasing health expenditures and a growing emphasis on patient safety, these End-users contribute significantly to the overall market growth. The country’s strict healthcare guidelines, as dictated by the Ministry of Health and Welfare, further propel the adoption of closed systems, ensuring that the End-users remain pivotal in driving market advancements. Additionally, emerging healthcare technologies and ongoing Research and Development efforts in South Korea are likely to amplify the demand for closed-system drug transfer devices across all segments, motivated by the need for safety, efficacy, and operational effectiveness in medication handling. ## **South Korea Closed System Drug Transfer Device Market Key Players and Competitive Insights** The competitive landscape of the South Korea Closed System Drug Transfer Device Market is characterized by a mix of established players and emerging companies striving for market share in a rapidly evolving segment. The market is influenced by increasing awareness regarding the safety of drug administration, coupled with the rising prevalence of hazardous drugs, prompting healthcare facilities to adopt closed systems that minimize exposure to toxic substances. This heightened focus on safety and regulatory compliance creates opportunities for innovation and differentiation through advanced product offerings. Companies are focusing on enhancing their market reach by expanding distribution channels and improving manufacturing capabilities to cater to the increasing demand from hospitals and specialty clinics in South Korea. ### **C.R. Bard** C.R. Bard presents a robust profile in the South Korea Closed System Drug Transfer Device Market. The company is recognized for its strong commitment to quality and innovation, providing a broad range of medical devices that are acclaimed for their effectiveness in enhancing drug safety. With a resilient distribution network established in the region, C.R. Bard has managed to maintain a significant market presence. Their continuous investment in research and development enables them to introduce cutting-edge solutions that comply with local regulatory standards while meeting the specific needs of healthcare providers. The company’s reputation for reliability and advanced technology ensures that it remains a formidable player in this competitive market landscape. ### **Vygon** Vygon also occupies a notable position within the South Korea Closed System Drug Transfer Device Market, emphasizing a strong portfolio of solutions tailored for effective drug transfer and safety. With key products that include specialized connectors and transfer devices, Vygon focuses on minimizing risks associated with drug handling in healthcare settings. Their presence in South Korea is reinforced by strategic partnerships and collaborations, enhancing their distribution capabilities across the region. Vygon's strengths lie in their deep understanding of the local market dynamics, allowing them to adapt their offerings to meet the unique requirements of patients and healthcare providers. The company is committed to sustainability and innovation, which is evident in its recent initiatives and product advancements aimed at improving healthcare outcomes. As part of Vygon's growth strategy, the company has pursued various mergers and acquisitions to broaden its technological capabilities and market reach, further solidifying its competitive stance in South Korea. ### **Key Companies in the South Korea Closed System Drug Transfer Device Market Include** ## **South Korea Closed System Drug Transfer Device Market Developments** Recent developments in the South Korea Closed System Drug Transfer Device Market indicate a proactive approach towards enhancing healthcare safety amid increasing concerns over drug contamination. Companies like C.R. Bard, Baxter, and ICU Medical are actively engaging in product innovations, focusing on ergonomic designs and user safety features. In September 2023, Baxter announced a strategic partnership with a local technological firm to initiate the development of advanced closed system devices tailored for the South Korean market, which aims to address local regulatory needs and enhance patient safety. Furthermore, the market is seeing a transition toward more eco-friendly materials in product development as part of a broader effort to meet sustainability targets set forth by South Korea's Ministry of Health. Growth in market valuation for major players like Fresenius Kabi and B. Braun has been noted, reflecting a robust demand driven by increasing healthcare expenditures and an aging population, which is projected to influence market dynamics significantly. In the last two years, Vygon successfully launched an upgraded closed system device in May 2022, focusing on ease of use and reducing risk for healthcare professionals. ## **South Korea Closed System Drug Transfer Device Market Segmentation Insights** ### **Closed System Drug Transfer Device Market Type Outlook** ### **Closed System Drug Transfer Device Market Component Outlook** ### **Closed System Drug Transfer Device Market Closing Mechanism Outlook** ### **Closed System Drug Transfer Device Market Technology Outlook** ### **Closed System Drug Transfer Device Market End-usersOutlook** ## Market Drivers ### Government Initiatives and Funding Government initiatives aimed at enhancing healthcare infrastructure in South Korea are significantly impacting the closed system-drug-transfer-device market. Increased funding for hospitals and healthcare facilities has led to the procurement of advanced medical equipment, including closed system-drug-transfer-devices. The South Korean government has allocated substantial budgets to improve patient care and safety, which is likely to boost the market. Reports suggest that public healthcare spending is expected to rise by 5% annually, creating a favorable environment for the adoption of these devices. This financial support not only facilitates the purchase of closed system-drug-transfer-devices but also encourages research and development in this sector. ### Increased Focus on Infection Control The heightened focus on infection control measures in healthcare settings is significantly influencing the closed system-drug-transfer-device market. South Korean healthcare facilities are implementing stringent protocols to prevent healthcare-associated infections, which has led to a surge in the demand for closed system-drug-transfer-devices. These devices are designed to minimize exposure to hazardous drugs and reduce the risk of contamination. The market is expected to grow as hospitals prioritize infection control in their operational strategies. Recent studies indicate that the adoption of closed systems can reduce infection rates by up to 30%, making them an essential component of modern healthcare practices. ### Rising Awareness of Safety Protocols The increasing awareness of safety protocols among healthcare professionals in South Korea is driving the closed system-drug-transfer-device market. As hospitals and clinics prioritize patient safety, the adoption of closed system-drug-transfer-devices is becoming more prevalent. This trend is reflected in the growing number of training programs and workshops aimed at educating healthcare staff about the risks associated with drug handling. The market is projected to grow at a CAGR of approximately 8% from 2025 to 2030, indicating a robust demand for these devices. Furthermore, regulatory bodies are emphasizing the importance of safety measures, which further propels the adoption of closed system-drug-transfer-devices in various healthcare settings. ### Growing Incidence of Chronic Diseases The rising incidence of chronic diseases in South Korea is a key driver for the closed system-drug-transfer-device market. As the population ages, the demand for effective drug delivery systems increases, particularly for patients requiring long-term medication. Chronic conditions such as diabetes and cancer necessitate the use of closed system-drug-transfer-devices to minimize contamination risks and ensure safe drug administration. Market analysis indicates that the prevalence of chronic diseases is projected to increase by 10% over the next decade, thereby expanding the market for these devices. Healthcare providers are increasingly recognizing the importance of using closed systems to enhance patient outcomes and reduce healthcare costs. ### Technological Integration in Healthcare The integration of advanced technologies in healthcare is transforming the closed system-drug-transfer-device market. Innovations such as smart devices and automated systems are enhancing the efficiency and safety of drug transfer processes. In South Korea, hospitals are increasingly adopting these technologies to streamline operations and reduce human error. The market is witnessing a shift towards devices that incorporate features like real-time monitoring and data analytics, which are expected to improve patient safety. It is estimated that the technological advancements in this sector could lead to a market growth of approximately 12% by 2027, as healthcare facilities seek to leverage these innovations for better patient care. ## Future Outlook The [Closed System Drug Transfer Device Market](https://www.marketresearchfuture.com/reports/closed-system-drug-transfer-device-market-7733) in South Korea is projected to grow at a 10.22% CAGR from 2025 to 2035, driven by increasing safety regulations and technological advancements. **New opportunities:** - Development of integrated software solutions for device monitoring. - Expansion into home healthcare markets with portable devices. - Partnerships with hospitals for customized training programs. By 2035, the market is expected to achieve substantial growth, reflecting evolving healthcare needs. ## Segment Insights ### By Type: Membrane-To-Membrane Systems (Largest) vs. Needleless Systems (Fastest-Growing) In the South Korea closed system-drug-transfer-device market, Membrane-To-Membrane Systems hold the largest share due to their established presence and reliability in the healthcare sector. These systems are favored for their efficiency in drug transfer processes, leading to a significant portion of the market being captured by this segment. Conversely, Needleless Systems, while currently smaller in market share, are rapidly gaining traction among healthcare professionals due to their safety features and ease of use, highlighting an evolving preference towards these innovative solutions. The growth of Membrane-To-Membrane Systems is driven by ongoing advancements in technology and increasing regulatory standards for drug transfer devices, ensuring safety and efficacy. Meanwhile, Needleless Systems are emerging as the fastest-growing segment thanks to rising awareness regarding needlestick injuries and the push for safer medical practices. This aligns with a broader trend towards minimizing risk and promoting user-friendly devices in healthcare settings, indicating a transformative shift in market dynamics. Technology: Membrane-To-Membrane Systems (Dominant) vs. Needleless Systems (Emerging) Membrane-To-Membrane Systems are characterized by their dual membrane design, which enhances safety and efficiency in drug transfers. This technology is predominantly utilized in hospitals and clinical settings where precision is vital. Their dominant market position is bolstered by longstanding trust from medical professionals who rely on their performance. In contrast, Needleless Systems are rapidly becoming an emerging player in the market, designed to eliminate the risks associated with traditional needle systems. They offer significant advantages in terms of user safety and convenience, appealing to healthcare providers seeking innovative solutions. The increasing adoption of Needleless Systems marks a significant shift in preference toward safer and more efficient drug transfer methodologies. ### By Component: Vial Access Devices (Largest) vs. Syringe Safety Devices (Fastest-Growing) The Component segment of the South Korea closed system-drug-transfer-device market showcases substantial diversity, with Vial Access Devices holding the largest market share due to their widespread adoption in pharmaceutical settings. This category has established itself as a cornerstone for secure drug transfer, outperforming other device types. Syringe Safety Devices, while currently not the largest, represent the fastest-growing segment as healthcare facilities increasingly prioritize safety protocols to minimize needle-stick injuries, driving awareness and adoption. Vial Access Devices (Dominant) vs. Syringe Safety Devices (Emerging) Vial Access Devices are a dominant force within the Component segment, characterized by their robust functionality and reliability in drug transfer processes. Their design allows for both efficient and safe access to vials, making them essential in reducing contamination risks. In contrast, Syringe Safety Devices are emerging as key players, rapidly gaining traction due to heightened emphasis on safety in healthcare environments. These devices not only enhance safety by preventing accidental needle sticks but also comply with regulatory standards, solidifying their position in future healthcare practices. Together, these segments illustrate the ongoing evolution in the South Korea closed system-drug-transfer-device market. ### By Closing Mechanism: Luer Lock Systems (Largest) vs. Click-To Lock System (Fastest-Growing) In the South Korea closed system-drug-transfer-device market, Luer Lock Systems command the largest share, benefiting from their widespread adoption and established trust among healthcare providers. Push To Turn and Color-To-Color Alignment Systems also contribute significant shares, but they are comparatively less prominent. The Click-To Lock System, although currently smaller, is rapidly gaining traction due to its innovative design and user-friendly features that enhance safety and efficiency. The growth trends in this segment are primarily driven by technological advancements and an increasing emphasis on patient safety. As healthcare facilities seek safer and more reliable drug transfer systems, Luer Lock Systems continue to lead the market. However, the Click-To Lock System is becoming increasingly appealing, particularly among younger healthcare professionals who favor modern, efficient products, signifying a potential shift in market dynamics. Luer Lock Systems (Dominant) vs. Click-To Lock System (Emerging) Luer Lock Systems are characterized by their secure and robust connection, making them a preferred choice among healthcare professionals for various applications in drug transfer. Their dominant position in the market stems from their reliability and compatibility with existing systems, thereby ensuring consistent usage across many settings. Conversely, the Click-To Lock System is emerging as a strong alternative, appealing to those who prioritize convenience and modernity. This system offers a simple locking mechanism that reduces the risk of accidental disengagement, aligning perfectly with the growing trend toward enhanced safety measures in medical practices. As both systems continue to evolve, their market dynamics will significantly shape the future landscape. ### By Technology: Compartmentalize Devices (Largest) vs. Diaphragm-Based Devices (Fastest-Growing) In the South Korea closed system-drug-transfer-device market, Compartmentalize Devices hold a significant share due to their crucial role in ensuring medication safety and effective drug transfer in clinical settings. This segment has gained popularity due to regulatory scrutiny and increasing healthcare standards, reinforcing its dominance in the market. On the other hand, Diaphragm-Based Devices, while smaller in share, are rapidly gaining traction due to their innovative design and efficiency in minimizing contamination risks, appealing to a more specialized consumer base. The growth trends in the technology segment are largely driven by advancements in device technology and increasing awareness regarding the importance of safety in drug transfer. Diaphragm-Based Devices are witnessing a surge in adoption, primarily due to their unique advantages, including ease of use and compatibility with various drug formulations. Furthermore, rising investments in healthcare infrastructure and the demand for safe drug handling in hospitals and clinics are expected to propel growth in this segment, establishing it as a key player in the market. Technology: Compartmentalize Devices (Dominant) vs. Diaphragm-Based Devices (Emerging) Compartmentalize Devices are characterized by their ability to efficiently segregate and manage different drug agents, which positions them as the dominant force in the South Korea closed system-drug-transfer-device market. These devices are essential for minimizing the risk of cross-contamination and ensuring regulatory compliance in healthcare settings. Conversely, Diaphragm-Based Devices are emerging steadily, recognized for their innovative designs and operational efficiency. These devices effectively minimize exposure to harmful substances and present a safer alternative for healthcare professionals. Their growing acceptance is supported by the shift towards advanced safety standards in the medical field, making them a compelling option for future investments. ### By End User: Hospitals & Clinics (Largest) vs. Specialty Centers (Fastest-Growing) In the South Korea closed system-drug-transfer-device market, Hospitals & Clinics lead the way with a significant market share, emphasizing their crucial role in healthcare delivery. Specialty Centers, though smaller in comparison, are quickly gaining traction, reflecting changing dynamics in patient care and treatment methodologies. Finally, the 'Others' category, which includes various healthcare facilities, plays a supportive role in accommodating diverse needs. Growth trends in this segment are driven by an increased focus on patient safety and medication handling efficiencies. Hospitals and Clinics remain dominant due to their volume of drug transfers, while Specialty Centers are emerging as key players due to specialized treatments requiring advanced drug transfer technologies. The rising incidence of chronic diseases and the demand for efficient healthcare solutions are also propelling this growth. Hospitals & Clinics (Dominant) vs. Specialty Centers (Emerging) Hospitals & Clinics represent the dominant end-user segment within the South Korea closed system-drug-transfer-device market, characterized by extensive drug administration procedures and a constant need for efficient delivery systems. Their large patient populations necessitate innovative devices for safe drug transfers, propelling market demand. On the other hand, Specialty Centers are marked as an emerging segment, driven by advances in personalized medicine and outpatient care. These centers are increasingly adopting closed-system devices to enhance safety for patients undergoing specialized treatments. Together, these segments underscore the importance of efficient drug transfer solutions in advancing healthcare outcomes. ## Competitive Benchmarking The closed system-drug-transfer-device market in South Korea is characterized by a competitive landscape that is increasingly shaped by innovation, regulatory compliance, and strategic partnerships. Key players such as Baxter International (US), B. Braun Melsungen AG (DE), and ICU Medical (US) are actively pursuing strategies that emphasize technological advancements and market expansion. Baxter International (US) has focused on enhancing its product portfolio through continuous innovation, while B. Braun Melsungen AG (DE) has prioritized regional expansion to strengthen its market presence. ICU Medical (US) appears to be leveraging strategic partnerships to enhance its distribution capabilities, thereby influencing the competitive dynamics of the market. The business tactics employed by these companies reflect a concerted effort to optimize supply chains and localize manufacturing processes. The market structure is moderately fragmented, with several players vying for market share. However, the collective influence of these key players is significant, as they drive advancements in product development and regulatory compliance, which are crucial for maintaining competitive advantage. In October 2025, Baxter International (US) announced the launch of a new closed system-drug-transfer-device designed to enhance safety and efficiency in drug administration. This strategic move is likely to reinforce Baxter's position as a leader in innovation within the market, catering to the growing demand for safer drug delivery systems. The introduction of this device may also serve to address regulatory pressures and improve patient outcomes, thereby solidifying Baxter's competitive edge. In September 2025, B. Braun Melsungen AG (DE) expanded its manufacturing capabilities in South Korea by investing in a new facility dedicated to the production of closed system-drug-transfer-devices. This investment not only signifies B. Braun's commitment to the South Korean market but also enhances its ability to meet local demand more effectively. The establishment of this facility is expected to streamline operations and reduce lead times, which could be pivotal in a market that values efficiency and reliability. In August 2025, ICU Medical (US) entered into a strategic partnership with a local distributor to enhance its market reach in South Korea. This collaboration is anticipated to improve ICU Medical's distribution network, allowing for better access to healthcare providers and hospitals. By aligning with a local partner, ICU Medical may effectively navigate regulatory challenges and cultural nuances, thereby positioning itself more favorably in the competitive landscape. As of November 2025, the closed system-drug-transfer-device market is witnessing trends that emphasize digitalization, sustainability, and the integration of artificial intelligence (AI) in product development. Strategic alliances are increasingly shaping the competitive environment, as companies seek to leverage complementary strengths. The shift from price-based competition to a focus on innovation, technology, and supply chain reliability is becoming evident. Moving forward, competitive differentiation will likely hinge on the ability to innovate and adapt to evolving market demands, ensuring that companies remain at the forefront of this dynamic industry. ## Recent News & Developments Recent developments in the South Korea Closed System Drug Transfer Device Market indicate a proactive approach towards enhancing healthcare safety amid increasing concerns over drug contamination. Companies like C.R. Bard, Baxter, and ICU Medical are actively engaging in product innovations, focusing on ergonomic designs and user safety features. In September 2023, Baxter announced a strategic partnership with a local technological firm to initiate the development of advanced closed system devices tailored for the South Korean market, which aims to address local regulatory needs and enhance patient safety. Furthermore, the market is seeing a transition toward more eco-friendly materials in product development as part of a broader effort to meet sustainability targets set forth by South Korea's Ministry of Health. Growth in market valuation for major players like Fresenius Kabi and B. Braun has been noted, reflecting a robust demand driven by increasing healthcare expenditures and an aging population, which is projected to influence market dynamics significantly. In the last two years, Vygon successfully launched an upgraded closed system device in May 2022, focusing on ease of use and reducing risk for healthcare professionals. ## Report Scope | MARKET SIZE 2024 | 24.0(USD Million) | | --- | --- | | MARKET SIZE 2025 | 26.45(USD Million) | | MARKET SIZE 2035 | 70.0(USD Million) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 10.22% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Million | | Key Companies Profiled | Baxter International (US), B. Braun Melsungen AG (DE), Cardinal Health (US), Cypress Medical Products (US), ICU Medical (US), Merit Medical Systems (US), Pall Corporation (US), Terumo Corporation (JP) | | Segments Covered | Type, Component, Closing Mechanism, Technology, End User | | Key Market Opportunities | Growing demand for safety and efficiency in drug handling drives innovation in the closed system-drug-transfer-device market. | | Key Market Dynamics | Regulatory changes and technological advancements drive growth in the closed system-drug-transfer-device market in South Korea. | | Countries Covered | South Korea | ## Frequently Asked Questions **Q: What is the current valuation of the closed system-drug-transfer-device market in South Korea?** A: The market valuation was $24.0 Million in 2024. **Q: What is the projected market valuation for 2035?** A: The market is projected to reach $70.0 Million by 2035. **Q: What is the expected CAGR for the closed system-drug-transfer-device market during the forecast period 2025 - 2035?** A: The expected CAGR is 10.22% during the forecast period. **Q: Which companies are the key players in the South Korean market?** A: Key players include Baxter International, B. Braun Melsungen AG, Cardinal Health, and others. **Q: What are the main types of closed system-drug-transfer-devices available in the market?** A: The main types include Membrane-To-Membrane Systems and Needleless Systems. **Q: How do the segment valuations for Needleless Systems compare to Membrane-To-Membrane Systems?** A: Needleless Systems had a valuation of $16.0 Million, while Membrane-To-Membrane Systems was valued at $8.0 Million. **Q: What components are included in the closed system-drug-transfer-device market?** A: Components include Vial Access Devices, Syringe Safety Devices, and Bag/Line Access Devices. **Q: What is the valuation range for Syringe Safety Devices in the market?** A: Syringe Safety Devices are valued between $8.0 Million and $22.0 Million. **Q: What technologies are utilized in closed system-drug-transfer-devices?** A: Technologies include Compartmentalize Devices, Diaphragm-Based Devices, and Air Filtration Devices. **Q: What are the primary end users of closed system-drug-transfer-devices?** A: Primary end users include hospitals & clinics, specialty centers, and others. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/south-korea-closed-system-drug-transfer-device-market-49667*